Zeige 320 Unternehmen für "Pharmaceuticals"
Unternehmen
Novo Nordisk ist ein globales Pharmaunternehmen, das sich auf die Behandlung von Diabetes, Adipositas und anderen schwerwiegenden chronischen Erkrankungen konzentriert. Sie bieten innovative Arzneimittel und Applikationssysteme und nehmen eine führende Position in der Diabetesversorgung ein. Das Unternehmen engagiert sich für nachhaltige Entwicklung und Patientenzugang.
Abbott ist ein globales Technologieunternehmen im Gesundheitswesen, das sich zum Ziel gesetzt hat, Menschen durch die Kraft der Gesundheit zu einem erfüllteren Leben zu verhelfen. Das Unternehmen bietet ein breit gefächertes Portfolio an führenden, wissenschaftlich fundierten Produkten in den Bereichen Diagnostik, Medizintechnik, Ernährung und Marken-Generika. Abbott ist mit FreeStyle Libre führend in der Diabetesversorgung und engagiert sich für die Verbesserung der Gesundheitsversorgung weltweit.
Abbott ist ein Healthcare-Unternehmen, das sich zum Ziel gesetzt hat, Menschen zu einem gesünderen Leben zu verhelfen. Sie entwickeln innovative Gesundheitstechnologien und -produkte, darunter Instrumente für das Diabetesmanagement, kardiovaskuläre Geräte, Diagnostika und Ernährungsprodukte. Mit über 135 Jahren Erfahrung ist Abbott in mehr als 160 Ländern tätig und beschäftigt über 114.000 Mitarbeiter, mit dem Ziel, die Gesundheitsversorgung weltweit zu verbessern.
Pfizer is a leading biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines and vaccines. The company's portfolio includes a wide range of treatments for areas like oncology, vaccines, and immunology. Pfizer is recognized for its global reach and commitment to improving patient health.
AstraZeneca is a global pharmaceutical company that researches, develops, and commercializes prescription medicines. They focus on therapy areas such as oncology, biopharmaceuticals, and rare diseases. AstraZeneca is known for its science-led approach and commitment to improving health worldwide.
Sanofi is an R&D-driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth. They focus on developing breakthrough innovations in medicines and vaccines, with expertise in immunology, oncology, and rare diseases. The company has a global presence and emphasizes sustainable and equitable access to healthcare. Sanofi strives to pursue the miracles of science so people can chase their dreams.
Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies. They are particularly known for their products in oncology and dermatology. The company has achieved significant progress in addressing unmet medical needs.
Novartis is a global healthcare company focused on discovering, developing and commercializing innovative medicines. They aim to improve and extend people’s lives by addressing significant unmet medical needs with a broad portfolio of pharmaceuticals, including treatments for oncology, immunology, and other therapeutic areas. With a commitment to ethical behavior and corporate responsibility, Novartis integrates ESG principles into its business practices.
Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.
We are a premier research-intensive biopharmaceutical company delivering innovative health solutions. We focus on the prevention and treatment of diseases in people and animals through leading-edge science. For over 130 years, we've developed important medicines and vaccines, aiming to save and improve lives globally. We foster inclusivity for a safe, sustainable future.
Yakult Honsha Co., Ltd. is a global company focused on contributing to the health and happiness of people around the world. They are best known for their probiotic dairy products, especially Yakult, a fermented milk drink containing *Lactobacillus casei* strain Shirota. Additionally, they offer a range of other food products, cosmetics, and pharmaceuticals, with a strong emphasis on research and development.
Regeneron is a biopharmaceutical company driven by scientific breakthroughs to create life-changing medicines for people with serious diseases. They focus on innovative solutions from biologics to genetic medicines. Their efforts redefine excellence and efficiency in research and development.
GSK unites science, technology, and talent to get ahead of disease. They focus on research and development within therapeutic areas like respiratory, immunology, oncology, and HIV. The company has a strong global presence and is committed to improving access to healthcare.
Novo Nordisk is a global healthcare company focused on discovering and developing innovative medicines to help people living with serious chronic diseases, primarily diabetes and obesity. They offer a range of pharmaceutical products and devices, including insulin and GLP-1 receptor agonists. Novo Nordisk holds a leading position in diabetes care and is committed to driving change to defeat other serious chronic conditions.
BioNTech is a global immunotherapy powerhouse aspiring to translate science into survival. They focus on developing drugs for cancer and infectious diseases by harnessing the full potential of the immune system. BioNTech is dedicated to improving the health of people worldwide through fundamental research and development of immunotherapies and mRNA vaccines.
Alnylam Pharmaceuticals is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics. They develop and commercialize medicines for genetic diseases. Their key products target rare diseases. Alnylam is a leader in RNAi technology, with a growing portfolio of approved therapies.
Servier ist ein unabhängiges, internationales Pharmaunternehmen, das sich auf den therapeutischen Fortschritt für Patienten konzentriert. Es investiert substanziell in Forschung und Entwicklung, insbesondere in den Bereichen Onkologie, Kardiometabolismus und Neurowissenschaften. Servier ist bekannt für seine langfristige Vision und sein Engagement für die Bedürfnisse der Patienten.
This company focuses on providing affordable and innovative medicines. Key areas include generics, API & services, innovative medicines, and consumer health solutions. They are expanding their portfolio through in-licensing and partnerships. The company aims to improve patient access to treatments and operate globally with a strong commitment to integrity and quality.
Kamada is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. It boasts a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities. The company drives profitable growth from commercial activities and expertise in the plasma-derived biopharmaceutical market. Noteworthy products include GLASSIA®, KEDRAB®, CYTOGAM®, HEPAGAM B®, VARIZIG® and WINRHO®SDF.
KalVista Pharmaceuticals is dedicated to advancing science to improve the lives of individuals, with an initial focus on hereditary angioedema (HAE). They are developing orally-delivered small molecule medicines to transform the HAE treatment landscape and address unmet patient needs. Their goal is to make a meaningful difference for people living with HAE by offering new possibilities for disease management. KalVista's lead product is an oral on-demand treatment for HAE.